Coccidioidomycosis (Valley Fever) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Condition: Rift Valley FeverIntervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF VaccineSponsor: U.S. Army Medical Research and Materiel CommandCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2007 Category: Research Source Type: clinical trials
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
Condition: CoccidioidomycosisInterventions: Drug: Posaconazole; Drug: FluconazoleSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2007 Category: Research Source Type: clinical trials
